Natural compounds with important medical potential found in Helleborus sp.

Central European Journal of Biology

Volumn 8, Issue 3, 2013, Pages 272-285

  Maior, Maria Cornelia ^a   Dobrotǎ, Cristina ^a  

^a BABE BOLYAI UNIVERSITY   (Romania)

Author keywords

Active compounds; Anticancer properties; Cytotoxicity; Helleborus sp.; Immunomodulation; Phytochemicals; Secondary metabolites; Therapeutic potential

Indexed keywords

HELLEBORUS; RANUNCULACEAE; VERATRUM;

EID: 84872001480     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-013-0129-x     Document Type: Review

References (109)

1. Toma C., Ruginǎ R., Medicinal plant's anatomy. Atlas, [Anatomia plantelor medicinale. Atlas], Romanian Academy Ed., Bucharest, 1998 (in Romanian).
2. Kemertelidze E. P., Biologically active compounds and original remedies from plants growing in Georgia, Bull. Georgian Natl. Acad. Sci., 2007, 175, 91-96.
3. van Tellingen C., Pliny's pharmacopoeia or the Roman treatment, Neth. Heart J., 2007, 15, 118-120.
4. Brussel D. E., Medicinal plants of Mt. Pelion, Greece, Econ. Bot., 2004, 58, S174-S202.
5. Ramoutsaki I. A., Askitopoulou H., Konsolaki E., Pain relief and sedation in Roman Byzantine texts: Mandragoras officinarum, Hyoscyamos niger and Atropa belladonna, International Congress Series, 2002, 1242, 43-50.
6. Ciulei I., Grigorescu E., Stǎnescu U., Medicinal plants, phytochemistry and phytotherapy [Plante medicinale, fitochimie si fitoterapie, Vol. 1], Medical Ed., Bucharest, 1993 (in Romanian).
7. Adams M., Althera W., Kessler M., Kluge M., Hamburger M., Malaria in the renaissance: Remedies from European herbals from the 16th and 17th century, J. Ethnopharmacol., 2011, 133, 278-288.
8. Scherrer A. M., Motti R., Weckerle C. S., Traditional plant use in the areas of Monte Vesole and Ascea, Cilento National Park (Campania, Southern Italy), J. Ethnopharmacol., 2005, 97, 129-143.
9. Fujita T., Sezik E., Tabata M., Yeşilada E., Honda G., Takeda Y., et al., Traditional medicine in Turkey VII. Folk medicine in Middle and West Black Sea regions, Econ. Bot., 1995, 49, 406-422.
10. Menković N., Šavikin K., Tasić S., Zdunić G., Stešević D., Milosavljević S., et al., Ethnobotanical study on traditional uses of wild medicinal plants in Prokletije Mountains (Montenegro), J. Ethnopharmacol., 2011, 133, 97-107.
11. Idolo M., Motti R., Mazzoleni S., Ethnobotanical and phytomedicinal knowledge in a longhistory protected area, the Abruzzo, Lazio and Molise National Park (Italian Apennines), J. Ethnopharmacol., 2010, 127, 379-395.
12. Duke J. A., Bogenschutz-Godwin M. J., duCellier J., Duke P.-A. K., Handbook of Medicinal Herbs, 2nd ed., CRC Press LLC, Boca Raton, Florida, 2002.
13. Adams M., Berset C., Kessler M., Hamburger M., Medicinal herbs for the treatment of rheumatic disorders-A survey of European herbals from the 16th and 17th century, J. Ethnopharmacol., 2009, 121, 343-359.
14. Gomes N. G. M., Campos M. G., Órfão J. M. C., Ribeiro C. A. F., Plants with neurobiological activity as potential targets for drug discovery, Prog. Neuro-Psychopharmacol Biol Psychiatry, 2009, 33, 1372-1389.
15. Jäger A. K., Gauguin B., Adsersen A., Gudiksen L., Screening of plants used in Danish folk medicine to treat epilepsy and convulsions, J. Ethnopharmacol., 2006, 105, 294-300.
16. Cornara L., La Rocca A., Marsili S., Mariotti M. G., Traditional uses of plants in the Eastern Riviera (Liguria, Italy), J. Ethnopharmacol., 2009, 125, 16-30.
17. Passalacqua N. G., De Fine G., Guarrera P. M., Contribution to the knowledge of the veterinary science and of the ethnobotany in Calabria region (Southern Italy), J. Ethnobiol. Ethnomed., 2006, 2, 52.
18. Pieroni A., Nebel S., Quave C., Münz H., Heinrich M., Ethnopharmacy of the ethnic Albanians (Arbëreshë) of northern Basilicata, Italy. Fitoterapia, 2002, 73, 217-241.
19. Jarić S., Popović Z., Mačukanović-Jocić M., Djurdjević L., Mijatović M., Karadžić B., et al., An ethnobotanical study on the usage of wild medicinal herbs from Kopaonik Mountain (Central Serbia), J. Ethnopharmacol., 2007, 111, 160-175.
20. Bogdan I., Nechifor A., Basea I., Hruban E., From Romanian folk medicine: nonspecific stimulus therapy using transcutaneous implantation of hellebore (Helleborus purpurascens, Fam. Ranunculaceae) in agriculturally useful animals, Dtsch. Tieraerztl. Wochenschr., 1997, 97, 525-529.
21. Pârvu C., Plant's Universe. Small encyclopaedia [Universul plantelor. Mica enciclopedie], 3rd ed., Encyclopaedia Ed., Bucharest, 2000 (in Romanian).
22. Hussain A., Khan M. N., Iqbal Z., Sajid M. S., An account of the botanical anthelmintics used in traditional veterinary practices in Sahiwal district of Punjab, Pakistan, J. Ethnopharmacol., 2008, 119, 185-190.
23. Pascual-Villalobos M. J., Robledo A., Screening for antiinsect activity in Mediterranean plants, Indust. Crops Prod., 1998, 8, 183-194.
24. Prieto J. M., Schaffner U., Barker A., Braca A., Siciliano T., Boevé J.-L., Sequestration of furostanol saponins by Monophadnus sawfly larvae, J. Chem. Ecol., 2007, 33, 513-524.
25. Flomenbaum N. E., Goldfrank L. R., Hoffman R. S., Howland M. A, Lewin N. A., Nelson L. S., Goldfrank's Toxicologic Emergencies, 8th ed., McGraw Hill Companies Inc., 2006.
26. Bruneton J., Pharmacognosy, Phytochemistry, Medicinal plants [Pharmacognosie, Phytochimie, Plantes medicinales], 4th ed., Tec & Doc Ed., Éditions médicales internationals, Paris, France, 2009 (in French).
27. True B. L., Dreisbach R. H., Dreisbach's Handbook of Poisoning: Prevention, Diagnosis & Treatment, 13th ed., The Parthenon Publishing Group, London, UK, 2002.
28. Cooper, M. R., Johnson A. W., Poisonous Plants & Fungi: An Illustrated Guide Stationery Office Books, Norwich, 1988.
29. Fuller T. C., McClintock E. M., Poisonous Plants of California, University of California Press, Berkeley, California, 1986.
30. Karaca S., Kulac M., Kucuker H., Phytodermatitis caused by Ceratocephalus falcatus (Ranunculaceae), Eur. J. Dermatol., 2005, 15, 404-405.
31. Frohne, D., Pfander, H. J., Poisonous Plants: a handbook for doctors, pharmacists toxicologists, biologists and veterinarians, 2nd ed. Manson Publishing Inc., London, 2005.
32. Karrer W., About hellebrin, a crystallized glycosid from Helleborus nigri roots [Über Hellebrin, ein kristalisiertes Glycosid aus Radix Hellebori nigri], Helv. Chim. Acta, 1943, 26, 1353 (in German).
33. Wissner W., Kating H., Botanical and phytochemical investigations of species of the genus Helleborus growing in Europe and Asian Minor. II. Comparative phytochemical investigations of the cardio active glycosides and saponins, Planta Med., 1974, 26, 228-249.
34. Wissner W., Kating H., Botanical and phytochemical investigations of species of the genus Helleborus growing in Europe and Asian Minor - III. The quantitative contents of hellebrin in plants of the natural biotops and in culture, Planta Med., 1974, 26, 364-374.
35. Dewick P. M., Medicinal Natural Products: A Biosynthetic Approach, 2nd ed., John Wiley & Sons Inc., New York, USA, 2002.
36. Gao H., Popescu R., Kopp B., Wang Z., Bufadienolides and their antitumor activity, Nat. Prod. Rep., 2011, 28, 953-969.
37. Cioca C., Cucu V., Quantitative determination of hellebrin in the rhizomes and roots of Helleborus purpurascens W. et K., Planta Med., 1974, 26, 250-253.
38. Muhr P., Kerek F., Dreveny D., Likussar W., Schubert-Zsilavecz M., The structure of hellebrin, Liebigs Ann., 1995, 2, 443-444.
39. Challinor V. L., Piacente S., De Voss J. J., NMR assignment of the absolute configuration of C-25 in furostanol steroidal saponins, Steroids, 2012, 77, 504-511.
40. Lacaille-Dubois M. A., Wagner H., A review of the biological and pharmacological activities of saponins, Phytomedicine, 1996, 2, 363-386.
41. Lacaille-Dubois M. A., Wagner H., Bioactive saponins from plants: An update, In: Atta-ur-Rahman (Ed.), Studies in Natural Products Chemistry, Vol. 21, Elsevier, 2000.
42. Lacaille-Dubois M. A., Bioactive saponins with cancer related and immunomodulatory activity: Recent developments, In: Atta-ur-Rahman (Ed.), Studies in Natural Products Chemistry, Vol. 32, Elsevier, 2005.
43. Dinan L., Phytoecdysteroids: biological aspects, Phytochemistry, 2001, 57, 325-339.
44. Walters D., Plant Defense: Warding off attack by pathogens, herbivores and parasitic plants, 1st ed., Blackwell Publishing Ltd., 2011.
45. Klein R., Phytoecdysteroids, Journal of American Herbalists Guild, 2004, 18-28.
46. Mares D., Antimicrobial activity of protoanemonin, a lactone from ranunculaceous plant. Mycopathologia, 1987, 98, 133-140.
47. Tocan V., Baron O., Antibiotic effect of protoanemonine isolated from Ranunculus oxyspermus M. B., Boll. Chim. Farm., 1969, 108, 789-791.
48. Misra S., Dixit S., Antifungal principle of Ranunculus sceleratus, Econ. Bot. 1980, 34, 362-367.
49. Minakata H., Komura H., Nakanishi K., Kada T., Protoanemonin, an antimutagen isolated from plants, Mutation Research/Genetic Toxicology, 1983, 116, 317-322.
50. Martin M. L., San Roman L., Dominguez A., In vitro activity of protoanemonin, an antifungal agent, Planta Med., 1990, 56, 66-69.
51. Dickens F., Jones H. E. H., Carcinogenic activity of a series of reactive lactones and related substances, Br. J. Cancer, 1961, 15, 85-100.
52. Habermehl G. G., Ziemer P., Mitteleuropäische Giftpflanzen und ihre Wirkstoffe [Central European poisonous plants and their active ingredients] Springer, Berlin, 1999 (in German).
53. Martin, M. L., Ortiz de Urbina A. V., Montero M. J., Carron R., San Roman L., Pharmacologic effects of lactones isolated from Pulsatilla alpina subsp. Aphfolia, J. Ethnopharmacol., 1988, 24, 185-191.
54. Roth L., Daunderer M., Kormann K., Giftpflanzen-Pflanzengifte [Poisonous plants-phytotoxins] Nikol Verlag, Hamburg, 2006 (in German).
55. Huang, Y.-H., Lee T.-H., Chan K.-J., Hsu F.-L., Wu Y.-C., Lee M.-H., Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes, J. Dermatol. Sci., 2008, 49, 115-123.
56. Hu Y., Chen X., Duan H., Hu, Y. L., Mu X., Pulsatilla decoction and its active ingredients inhibit secretion of NO, ET-1, TNF-alpha, and IL-1 alpha in LPSinduced rat intestinal microvascular endothelial cells, Cell Biochem. Funct., 2009, 27, 284-288.
57. Duan H., Zhang Y., Xu J., Qiao J., Suo Z., Hu G., Mu X., Effect of anemonin on NO, ET-1 and ICAM-1 production in rat intestinal microvascular endothelial cells, J. Ethnopharmacol., 2006, 104, 362-366.
58. Lee T. H., Huang N. K., Lai T. C., Yang A. T. Y., Wang G. J., Anemonin, from Clematis crassifolia, potent and selective inducible nitric oxide synthase inhibitor, J. Ethnopharmacol., 2008, 116, 518-527.
59. Colombo M. L., Tome' F., Servettaz O., Bugatti C., Phytochemical evaluation of Helleborus species growing in northern Italy, Pharm. Biol., 1990, 28, 219-223.
60. Dirsch V., Lacaille-Dubois M.-A., Wagner H., Dracoside, a new steroidal saponin from Helleborus purpurascens, Nat. Prod. Lett., 1994, 4, 29-33.
61. Meng Y., Whiting P., Šik V., Rees H. H., Dinan L., Ecdysteroids and bufadienolides from Helleborus torquatus (Ranunculaceae), Phytochemistry, 2001, 57, 401-407.
62. Maleš Z., Medić-Šarić M., Optimization of TLC analysis of flavonoids and phenolic acids of Helleborus atrorubens Waldst. et Kit., J. Pharm. Biomed. Anal., 2001, 24, 353-359.
63. Watanabe K., Mimaki Y., Sakuma C., Sashida Y., A novel polyoxygenated spirostanol trisdesmoside from the rhizomes of Helleborus orientalis, Chem. Lett., 2002, 31, 772-773.
64. Watanabe K., Mimaki Y., Sakagami H., Sashida Y., Bufadienolide and spirostanol glycosides from the rhizomes of Helleborus orientalis, J. Nat. Prod., 2003, 66, 236-241.
65. Watanabe K., Sakagami H., Mimaki Y., Four new steroidal saponins from the rhizomes of Helleborus orientalis, Heterocycles, 2005, 65, 775-785.
66. Mimaki Y., Watanabe K., Sakuma C., Sakagami H., Sashida Y., Novel polyoxygenated spirostanol glycosides from the rhizomes of Helleborus orientalis, Helv. Chim. Acta, 2003, 86, 398-407.
67. Braca A., Prieto J. M., De Tommasi N., Tomè F., Morelli I., Furostanol saponins and quercetin glycosides from the leaves of Helleborus viridis L., Phytochemistry, 2004, 65, 2921-2928.
68. Akin S., Anil H., A furostanol saponin and phytoecdysteroid from roots of Helleborus orientalis, Chem. Nat. Compd., 2007, 43, 90-92.
69. Prieto J. M., Siciliano T., Braca A., A new acylated quercetin glycoside and other secondary metabolites from Helleborus foetidus, Fitoterapia, 2006, 77, 203-207.
70. Muzashvili T. S., Benidze M. M., Skhirtladze A. V., Sulakvelidze Ts. P., Steroidal sapogenins from subterranean organs of Helleborus caucasicus, Chem. Nat. Compd., 2006, 42, 613.
71. Bassarello C., Muzashvili T., Skhirtladze A., Kemertelidze E., Pizza C., Piacente S., Steroidal glycosides from the underground parts of Helleborus caucasicus, Phytochemistry, 2008, 69, 1227-1233.
72. Muzashvili T. S., Kemertelidze E. P., Steroidal compounds from Helleborus caucasicus leaves, Chem. Nat. Compd., 2009, 45, 925-926.
73. Rosselli S., Maggio A., Bruno M., Spadaro V., Formisano C., Irace C., et al., Furostanol saponins and ecdysones with cytotoxic activity from Helleborus bocconei ssp. intermedius, Phytother. Res., 2009, 23, 1243-1249.
74. Mimaki Y., Matsuo Y., Watanabe K., Sakagami H., Furostanol glycosides from the rhizomes of Helleborus orientalis, J. Nat. Med., 2010, 64, 452-459.
75. Yang J., Zhang Y.-H., Miao F., Zhou L., Sun W., Two new bufadienolides from the rhizomes of Helleborus thibetanus Franch, Fitoterapia, 2010, 81, 636-639.
76. Yang F.-Y., Su Y.-F., Wang Y., Chai X., Han X., Wu Z.-H., et al., Bufadienolides and phytoecdysones from the rhizomes of Helleborus thibetanus (Ranunculaceae), Biochem. Sys. Ecol., 2010, 38, 759-763.
77. Stochmal A., Perrone A., Piacente S., Oleszek W., Saponins in aerial parts of Helleborus viridis L., Phytochem. Lett., 2010, 3, 129-132.
78. Muzashvili T., Perrone A., Napolitano A., Kemertelidze E., Pizza C., Piacente S., Caucasicosides E-M, furostanol glycosides from Helleborus caucasicus, Phytochemistry, 2011, 72, 2180-2188.
79. Vitalini S., Braca A., Fico G., Study on secondary metabolite content of Helleborus niger L. leaves, Fitoterapia, 2011, 82, 152-154.
80. Stec B., Plant thionins - the structural perspective, Cell. Mol. Life Sci., 2006, 63, 1370-1385.
81. Milbradt A. G., Kerek F., Moroder L., Renner C., Structural Characterization of Hellethionins from Helleborus purpurascens, Biochemistry, 2003, 42, 2404-2411.
82. Bhave M., Methuku D. R., Small cysteinerich proteins from plants: a rich resource of antimicrobial agents, In: Science against microbial pathogens: communicating current research and technological advances, Ed. A. Méndez-Vilas, 2011, 1074-1083.
83. Pelegrini P. B., Franco O. L., Plant γ-thionnins: Novel insights of the mechanism of action of the multi-functional class of defence proteins, Int. J. Biochem. Cell B., 2005, 37, 2239-2253.
84. Kerek F., Boicil, a new and very efficient antialgic, spasmolytic, and blood vessel regulating drug obtained from the plant Helleborus. First International Conference on Chemistry and Biochemistry of Biologically Active Natural Compounds (FECS, 1981), 2, 22-37.
85. Erdemoglu N., Küpeli E., Yeşilada E., Antiinflammatory and antinociceptive activity assessment of plants used as remedy in Turkish folk medicine, J. Ethnopharmacol., 2003, 89, 123-129.
86. Nueleanu V. I., The effect of the unspecific therapy with hellebore (Helleborus purpurascens) on young sheep, Proceedings. Animal Husbandry. 43rd Croatian and 3rd International Symposium on Agriculture, (18-21 February 2008, Opatija, Croatia), 791-794.
87. Davidović V., Joksimović Todorović M., Stojanović B., Relić, R., Plant usage in protecting the farm animal health, Biotechnology in Animal Husbandry, 2012, 28, 87-98.
88. Lupu A. R., MCS-18 - potential therapeutic agent in neuro-immunological pathology [MCS-18 - potential agent terapeutic in patologii neuroimune], Ph. D. Thesis, University of Bucharest, Faculty of Biology, Bucharest, Romania, 2009 (in Romanian).
89. Kerek F., Stimac R., Apell H.-J., Freudenmann F., Moroder L., Characterization of the macrocyclic carbon suboxide factors as potent Na, K-ATPase and SR Ca-ATPase inhibitors, Biochim. Biophys. Acta, 2002, 1567, 213-220.
90. Kerek F., The structure of the digitalis like and natriuretic factors identified as macrocyclic derivatives of the inorganic carbon suboxide, Hypertens. Res., 2000, 23, 33-38.
91. Szegli G., Herold A., Cremer L., Cǎlugaru A., Matache C., Durbaca S., et al., Immunpharmacology studies on MCS-18, Investigational Medicinal Product Dossier, 2005, Part 2. 2, 1-42.
92. Kerek F., Szegli G., Cremer L., Lupu A. R., Durbaca S., Cǎlugaru A., et al., The novel arthritis drug-substance MCS-18 down-regulates in vivo antibody production, Acta Microbiol. Immunol. Hung., 2008, 55, 15-31.
93. Neacşu C., Ciobanu C., Barbu I., Toader O., Szegli G., Kerek F., et al., Substance MCS-18 isolated from Helleborus purpurascens is a potent antagonist of the capsaicin receptor, TRPV1, in rat cultured sensory neurons, Physiol. Res., 2010, 59, 289-298.
94. Horstmann B., Zinser E., Turza N., Kerek F., Steinkasserer A., MCS-18, a novel natural product isolated from Helleborus purpurascens, inhibits dendritic cell activation and prevents autoimmunity as shown in vivo using the EAE model, Immunobiology, 2008, 212, 839-853.
95. Littmann L., Rößner S., Kerek F., Steinkasserer A., Zinser E., Modulation of murine bone marrowderived dendritic cells and B-cells by MCS-18 a natural product isolated from Helleborus purpurascens, Immunobiology, 2008, 213, 871-878.
96. Seifarth C., Littmann L., Resheq Y., Rößner S., Goldwich A., Pangratz N., et al., MCS-18, a novel natural plant product prevents autoimmune diabetes, Immunol. Lett., 2011, 139, 58-67.
97. Apetrei N. S., Lupu A.-R., Calugaru A., Kerek F., Szegli G., Cremer L., The antioxidant effects of some progressively purified fractions from Helleborus purpurascens, Rom. Biotechnol. Lett., 2011, 16, 6673-6681.
98. Pǎun-Roman G., Neagu E., Radu G. L., Membrane processes for the purification and concentration of Helleborus purpurascens extracts and evaluation of antioxidant activity, Rev. Chim. (Bucharest), 2010, 61, 877-881.
99. Čakar J., Parić A., Vidic D., Haverić A., Haverić S., Maksimović M., et al., Antioxidant and antiproliferative activities of Helleborus odorus Waldst. & Kit, H. multifidus Vis. and H. hercegovinus Martinis, Nat. Prod. Res., 2011, 25, 1969-1974.
100. Trenin D. S., Volodin V. V., 20-hydroxyecdysone as a human lymphocyte and neutrophil modulator: In vitro evaluation, Arch. Insect Biochem. Physiol., 1999, 41, 156-161.
101. Puglisi S., Speciale A., Acquaviva R., Ferlito G., Ragusa S., De Pasquale R., et al., Antibacterial activity of Helleborus bocconei Ten. subsp. siculus root extracts, J. Ethnopharmacol., 2009, 125, 175-177.
102. Rosselli S., Maggio A., Formisano C., Napolitano F., Senatore F., Spadaro V., et al., Chemical composition and antibacterial activity of extracts of Helleborus bocconei Ten. subsp. intermedius, Nat. Prod. Commun., 2007, 2, 675-679.
103. Lindholm P., Gullbo J., Claeson P., Göransson U., Johansson S., Backlund A., et al., Selective cytotoxicity evaluation in anticancer drug screening of fractionated plant extracts, J. Biomol. Screen., 2002, 7, 333-340.
104. Muzashvili T., Skhirtladze A., Sulakvelidze T., Benidze M., Mshviladze V., Legault J., et al., Cytotoxic activity of Helleborus caucasicus A. Br., Georg. Chem. J., 2006, 6, 684-685.
105. Jesse P., Mottke G., Eberle J., Seifert G., Henze G., Prokop A., Apoptosis-inducing activity of Helleborus niger in ALL and AML, Pediatr. Blood Cancer, 2009, 52, 464-469.
106. Vochita G., Mihai C. T., Gherghel D., Iurea D., Roman G., Radu G. L., et al., New potential antitumoral agents of polyphenolic nature obtained from Helleborus purpurascens by membranary micro- and ultrafiltration techniques, SAAIC, 2011, 12, 41-51.
107. Büssing A., Schweizer K., Effects of a phytopreparation from Helleborus niger on immunocompetent cells in vitro, J. Ethnopharmacol., 1998, 59, 139-146.
108. Smulders M. J. M., de Klerk G. J., Epigenetics in Plant Tissue Culture, J. Plant Growth Regul., 2011, 63 137-146.
109. Grabowski K., Schneider G., Properties and Architecture of Drugs and Natural Products Revisited, Curr. Chem. Biol., 2007, 1, 115-127.